Chris Garabedian, CEO, Xontogeny & Portfolio Manager, PXV Fund, Alyssa Abo, MD, MBA, & Suzy Engwall
🚀 Thrilled to catch up with Chris Garabedian, CEO of Xontogeny and Portfolio Manager of PxV Fund, alongside industry pros Alyssa Abo, MD, MBA, and Suzy Engwall, at the HLTH Conference! We dove into some powerful trends driving healthcare innovation and investment—here’s a taste of the conversation:
🌟 On the Hunt for Breakout Companies: Chris is laser-focused on identifying companies on the verge of breakout, paying close attention to their customer base and the real traction they’re making in the market.
🔥 A Wave of Mergers & Acquisitions: A recent conversation with a healthcare leader revealed a startling reality—50% of today’s startups might not be around next year. This climate is sparking a wave of matchmaking between startups and suitors, as companies look for strategic partners to ensure longevity and success.
🎯 Why Team Matters: When investing in early-stage companies, Chris is all about the people. His focus? Founders’ networks, their track records, and what sets their solutions apart in a competitive landscape.
⚡ The Rise of Consumer-Centric Healthcare: The consumerization of healthcare is sparking incredible growth and reshaping the market, but it’s still challenging to pick winners. Healthcare remains a complex arena where innovative technology is essential, but standard reimbursement models continue to be the backbone of long-term viability.
Exciting times ahead as we witness the rapid disruption of healthcare. 📈💥
#HLTH2024#healthcareinnovation#venturecapital#Xontogeny#healthcarestartups#ConsumerHealth#mergersandacquisitions#healthtechPlanetary Health First Mars Next#planetaryhealthfirstmarsnext
Chris Garabedian, CEO, Xontogeny & Portfolio Manager, PxV Fund, Alyssa Abo, MD, MBA, & Suzy Engwall
🚀 Thrilled to catch up with Chris Garabedian, CEO of Xontogeny and Portfolio Manager of PxV Fund, alongside industry pros Alyssa Abo, MD, MBA, and Suzy Engwall, at the HLTH Conference! We dove into some powerful trends driving healthcare innovation and investment—here’s a taste of the conversation:
🌟 On the Hunt for Breakout Companies: Chris is laser-focused on identifying companies on the verge of breakout, paying close attention to their customer base and the real traction they’re making in the market.
🔥 A Wave of Mergers & Acquisitions: A recent conversation with a healthcare leader revealed a startling reality—50% of today’s startups might not be around next year. This climate is sparking a wave of matchmaking between startups and suitors, as companies look for strategic partners to ensure longevity and success.
🎯 Why Team Matters: When investing in early-stage companies, Chris is all about the people. His focus? Founders’ networks, their track records, and what sets their solutions apart in a competitive landscape.
⚡ The Rise of Consumer-Centric Healthcare: The consumerization of healthcare is sparking incredible growth and reshaping the market, but it’s still challenging to pick winners. Healthcare remains a complex arena where innovative technology is essential, but standard reimbursement models continue to be the backbone of long-term viability.
Exciting times ahead as we witness the rapid disruption of healthcare. 📈💥
#HLTH2024#healthcareinnovation#venturecapital#Xontogeny#healthcarestartups#ConsumerHealth#mergersandacquisitions#healthtechPlanetary Health First Mars Next#planetaryhealthfirstmarsnext
Dear Venture Capital Investors, Angel Investors, & all those who help fund cures and treatments for people via companies outside of Philadelphia - May I draw your attention to page 8!? This page clearly shows there are investors who may know something you did not. However, I am here to help you. Philly is creating global cures & treatments for people who have awful things they do not want, like tumors, blindness, COVID, etc. If you would like a return on your investment, invest in Philly life science companies!!!!! #lifescienceindustry#lifesciences#lifescience#philadelphia#philanthropy#angelinvestors#venturecapital
New: 8VC, a tech and life sciences investor behind startups like longevity biotech Altos Labs, is raising a $1 billion fund. The Austin-based firm outlined the plans for the sixth fund in an SEC filing on Wednesday.
#8VC#lifesciencesvc#biotechvc#healthvc#venturecapitalfund
DON Healthcare launches new VC and Family Office Network that has already exceeded 500 companies and growing.
DON Healthcare has collated and evaluated over 500 of the most important Venture Capital Firms and Family Offices at the decision-maker level seeking to invest in healthcare opportunities.
This live and interactive Network, staffed by actual account managers, links entrepreneurs and CEOs with appropriate venture capital firms.
More information - https://lnkd.in/ejTA73MQ#HealthcareInnovation#VentureCapital#FamilyOffices#HealthcareInvestment
Before I started Suncoast in 2021, I couldn’t fathom starting a venture capital fund of my own. It just didn’t feel within the realm of what could be possible for me. In all fairness, when I first started out in this industry I could count the number of women VC check writers on both fingers (no toes). There were about 8-10 in the U.S... 🙄
So I wanted to start with a syndicate instead so I could build my reputation, nurture relationships, and over time possibly start a fund. Obviously there were other plans in store for me.
Launching Fund I was a massive effort and I had no time to pursue a syndicate. And for strategic reasons it didn't make sense. But I still went around telling everyone I was going to do one someday! Which is why I'm excited to share - there is now a syndicate attached to Suncoast! 🥳
Announcing the Suncoast Healthcare Equity Angels!
I'm so excited to join forces with HEA to launch our Syndicate, as I have been working with them from the very beginning. We would not be where we are today without their support and the support of Jack Topdjian! ⭐ We have worked together, co-invested in deals, and together we will be even stronger and more powerful.
With 20 angel advisers already, HEA's expertise is across all key healthcare domains, technology, and early-stage companies.
Suncoast Healthcare Equity Angels is By Invitation Only.
Requirements to participate are:
-Commit to write at least 1 check per year.
-Be available for at least 1 hour of mentorship/advising per month with a portfolio company founder.
Benefits to participation are:
-Leverage the extensive dealflow, due-diligence and expertise of Suncoast Ventures and the syndicate at large
-Professionally managed dealflow operations, run by Suncoast Ventures.
-Be part of a network of like-minded people who are passionate about transforming health and want to make it more equitable and accessible through technology.
-Invitations to special events throughout the year.
If you or someone you know might be interested in getting involved with us, send me a DM and let's talk!
Healthcare Equity AngelsDr. Tammy MahaneyChima OsukaRay CostantiniHal WalbrinkSuncoast Ventures#healthequity#healthimpact#medtech#digitalhealth#healthtech#globalhealth#medicalai
CalmWave, a Seattle, WA-based creator of the Quiet ICU, raised $5.25M in funding. Third Prime led the round, which included participation from Catalyst by Wellstar, Silver Circle, Rebellion, Impulsum, and existing investors Bonfire Ventures, Tau Ventures, and Hike Ventures. https://lnkd.in/gCM9GJ2Y
📱 Mercia Ventures has continued its commitment into Little Journey by supporting them in a £6m Series A funding round.
The healthtech company is transforming the delivery of paediatric care through personalised psychological support, with the funding being used to scale Little Journey’s operations globally with a focus on the US healthcare market.
Mercia Ventures invested alongside the Northern Powerhouse Investment Fund I (NPIF I), Par Equity, Octopus Ventures, Calm/Storm and angel investors.
Read more (link in comments) ⏬
#NPIF#EIS#Investment#SeriesA#HealthTech#VC | British Business Bank North of England
